Elevai Labs Inc. Common S... (ELAB)
Elevai Labs Common Stock Statistics
Share Statistics
Elevai Labs Common Stock has 577.47K shares outstanding. The number of shares has increased by 5963.46% in one year.
| Shares Outstanding | 577.47K |
| Shares Change (YoY) | 5963.46% |
| Shares Change (QoQ) | 2028.25% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 572.15K |
| Failed to Deliver (FTD) Shares | 12.89K |
| FTD / Avg. Volume | 3.4% |
Short Selling Information
The latest short interest is 9.42M, so 306.65% of the outstanding shares have been sold short.
| Short Interest | 9.42M |
| Short % of Shares Out | 306.65% |
| Short % of Float | 310.41% |
| Short Ratio (days to cover) | 0.17 |
Valuation Ratios
The PE ratio is -914.33 and the forward PE ratio is null. Elevai Labs Common Stock's PEG ratio is -8.27.
| PE Ratio | -914.33 |
| Forward PE | n/a |
| PS Ratio | 2296.52 |
| Forward PS | null |
| PB Ratio | 1027.68 |
| P/FCF Ratio | -860.99 |
| PEG Ratio | -8.27 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Elevai Labs Inc. Common Stock.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.79 |
| Quick Ratio | 3.41 |
| Debt / Equity | 0.05 |
| Total Debt / Capitalization | 5.21 |
| Cash Flow / Debt | -21.65 |
| Interest Coverage | -187.92 |
Financial Efficiency
Return on equity (ROE) is -1.12% and return on capital (ROIC) is -90.87%.
| Return on Equity (ROE) | -1.12% |
| Return on Assets (ROA) | -0.83% |
| Return on Capital (ROIC) | -90.87% |
| Revenue Per Employee | $95,144.17 |
| Profits Per Employee | $-238,973.17 |
| Employee Count | 18 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.17 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -96.39% in the last 52 weeks. The beta is -2.99, so Elevai Labs Common Stock's price volatility has been lower than the market average.
| Beta | -2.99 |
| 52-Week Price Change | -96.39% |
| 50-Day Moving Average | 9.82 |
| 200-Day Moving Average | 38.76 |
| Relative Strength Index (RSI) | 36.25 |
| Average Volume (20 Days) | 378.82K |
Income Statement
In the last 12 months, Elevai Labs Common Stock had revenue of 1.71M and earned -4.3M in profits. Earnings per share was -0.4.
| Revenue | 1.71M |
| Gross Profit | 1.13M |
| Operating Income | -3.67M |
| Net Income | -4.3M |
| EBITDA | -4.27M |
| EBIT | -3.67M |
| Earnings Per Share (EPS) | -0.4 |
Balance Sheet
The company has 3.33M in cash and 210.49K in debt, giving a net cash position of 3.12M.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | 210.49K |
| Net Cash | 3.12M |
| Retained Earnings | -7.02M |
| Total Assets | 11.21M |
| Working Capital | 6.1M |
Cash Flow
In the last 12 months, operating cash flow was -4.56M and capital expenditures -11.19K, giving a free cash flow of -4.57M.
| Operating Cash Flow | -4.56M |
| Capital Expenditures | -11.19K |
| Free Cash Flow | -4.57M |
| FCF Per Share | -0.43 |
Margins
Gross margin is 66.25%, with operating and profit margins of -214.24% and -251.17%.
| Gross Margin | 66.25% |
| Operating Margin | -214.24% |
| Pretax Margin | -251.17% |
| Profit Margin | -251.17% |
| EBITDA Margin | -249.35% |
| EBIT Margin | -214.24% |
| FCF Margin | -266.73% |
Dividends & Yields
ELAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.97% |
| FCF Yield | -157.58% |
Analyst Forecast
Currently there are no analyst rating for ELAB.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 10, 2025. It was a backward split with a ratio of 1:7.
| Last Split Date | Mar 10, 2025 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -1.27 |
| Piotroski F-Score | 2 |